This post was originally published on this site

SPACs are all the rage today. With the IPO market booming and public investors seeking better returns, blank check companies called “Special Purpose Acquisition Companies” (SPACs) have been fueling up their tanks and chasing down their merger targets. New ones are getting announced every day, including in biotech: so much so that serial entrepreneur MikeRead More »

The post It’s Raining Biotech SPACs! appeared first on Atlas Venture.